These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25295280)

  • 21. The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better.
    Peters MJ; Voskuyl AE; Sattar N; Dijkmans BA; Smulders YM; Nurmohamed MT
    Int J Clin Pract; 2010 Sep; 64(10):1440-3. PubMed ID: 20716150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atherogenic lipid profile and high sensitive C-reactive protein in patients with rheumatoid arthritis.
    Singh HV; Shrivastava AK; Raizada A; Singh SK; Pandey A; Singh N; Yadav D; Sharma H
    Clin Biochem; 2013 Aug; 46(12):1007-1012. PubMed ID: 23578742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of Non-Fasting Lipid Profile for the Assessment of Lipoprotein Coronary Risk.
    Fatima S; Ijaz A; Sharif TB; Khan DA; Siddique A
    J Coll Physicians Surg Pak; 2016 Dec; 26(12):954-957. PubMed ID: 28043305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study.
    Georgiadis AN; Papavasiliou EC; Lourida ES; Alamanos Y; Kostara C; Tselepis AD; Drosos AA
    Arthritis Res Ther; 2006; 8(3):R82. PubMed ID: 16646989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trial.
    Toth PP; Jones SR; Slee A; Fleg J; Marcovina SM; Lacy M; McBride R; Boden WE
    J Clin Lipidol; 2018; 12(3):741-747.e11. PubMed ID: 29627296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.
    Popa C; van den Hoogen FH; Radstake TR; Netea MG; Eijsbouts AE; den Heijer M; van der Meer JW; van Riel PL; Stalenhoef AF; Barrera P
    Ann Rheum Dis; 2007 Nov; 66(11):1503-7. PubMed ID: 17472994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipid profile and cardiovascular risk in patients with rheumatoid arthritis: Effect of the disease and of drug therapy].
    Hansel B; Bruckert E
    Ann Endocrinol (Paris); 2010 Sep; 71(4):257-63. PubMed ID: 20416859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study.
    Park YB; Choi HK; Kim MY; Lee WK; Song J; Kim DK; Lee SK
    Am J Med; 2002 Aug; 113(3):188-93. PubMed ID: 12208376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial.
    Charles-Schoeman C; Wang X; Lee YY; Shahbazian A; Navarro-Millán I; Yang S; Chen L; Cofield SS; Moreland LW; O'Dell J; Bathon JM; Paulus H; Bridges SL; Curtis JR
    Arthritis Rheumatol; 2016 Mar; 68(3):577-86. PubMed ID: 26606398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The analysis of the lipid levels in patients with coronary artery disease after percutaneous coronary intervention: a one-year follow-up observational study.
    Qiu W; Chen J; Huang X; Guo J
    Lipids Health Dis; 2020 Jul; 19(1):163. PubMed ID: 32631347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients.
    Morris SJ; Wasko MC; Antohe JL; Sartorius JA; Kirchner HL; Dancea S; Bili A
    Arthritis Care Res (Hoboken); 2011 Apr; 63(4):530-4. PubMed ID: 21452265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein-defined lipoprotein abnormalities in rheumatoid arthritis patients and their potential impact on cardiovascular disease.
    Knowlton N; Wages JA; Centola MB; Alaupovic P
    Scand J Rheumatol; 2012 May; 41(3):165-9. PubMed ID: 22401593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
    Navarro JF; Mora C; Muros M; García-Idoate G
    Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case-control study on the association between serum lipid level and the risk of breast cancer].
    Wei LJ; Zhang C; Zhang H; Wei X; Li SX; Liu JT; Ren XB
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1091-1095. PubMed ID: 28057114
    [No Abstract]   [Full Text] [Related]  

  • 35. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease.
    Myasoedova E; Crowson CS; Kremers HM; Roger VL; Fitz-Gibbon PD; Therneau TM; Gabriel SE
    Ann Rheum Dis; 2011 Mar; 70(3):482-7. PubMed ID: 21216812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group.
    Ettinger WH; Wahl PW; Kuller LH; Bush TL; Tracy RP; Manolio TA; Borhani NO; Wong ND; O'Leary DH
    Circulation; 1992 Sep; 86(3):858-69. PubMed ID: 1516198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein.
    Rodríguez-Carrio J; Alperi-López M; López P; López-Mejías R; Alonso-Castro S; Abal F; Ballina-García FJ; González-Gay MÁ; Suárez A
    J Clin Lipidol; 2017; 11(4):1043-1054.e2. PubMed ID: 28662934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis.
    Kiortsis DN; Mavridis AK; Filippatos TD; Vasakos S; Nikas SN; Drosos AA
    J Rheumatol; 2006 May; 33(5):921-3. PubMed ID: 16541480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment.
    Cacciapaglia F; Anelli MG; Rinaldi A; Fornaro M; Lopalco G; Scioscia C; Lapadula G; Iannone F
    Mediators Inflamm; 2018; 2018():2453265. PubMed ID: 30405318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.